Ilorasertib, CAS [[1227939-82-3]]

Produktübersicht

• Artikelname: Ilorasertib, CAS [[1227939-82-3]]
• Artikelnummer: MCE-HY-16018
• Hersteller Artikelnummer: HY-16018
• Alternativnummer: MCE-HY-16018-5MG,MCE-HY-16018-100MG,MCE-HY-16018-50MG,MCE-HY-16018-10MMX1ML,MCE-HY-16018-25MG,MCE-HY-16018-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ABT-348

Produktbeschreibung

Ilorasertib (ABT-348) is a potent, orally active and ATP-competitive aurora inhibitor with IC50s of116, 5, 1 nM for aurora A, aurora B, aurora C, respectively. Ilorasertib also is a potent VEGF, PDGF inhibitor. Ilorasertib has the potential for the research of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)[1][2].

Produkteigenschaften

• Molekulargewicht: 488.54
• Reinheit: 99.86
• CAS Nummer: [1227939-82-3]
• Formel: C25H21FN6O2S
• Target-Kategorie: Aurora Kinase,PDGFR,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound